Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith our Press Release relating to first quarter FY19 financials, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you, Outcome of Board Meeting
Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Tuesday, August 14, 2018, duly approved the Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30, 2018, which are enclosed herewith alongwith the Limited Review Report of the... Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 180 (One Hundred and Eighty) equity shares of Re. 1/- each under ESOS, at the Meeting of the Committee of Directors (Allotment) held today Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Valia Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has now received the reivsed disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pratham Investments Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pratham Investments Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are pleased to enclose herewith our Press Release relating to launch of Novel Drug Kapspargo Sprinkle in USA, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you, Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Sudhir Valia
Sun Pharma recalls testosterone cypionate injections from US
Sun Pharma is recalling 5,215 units of 10 ml vials of testosterone cypionate injections in the strength of 200 mg/ml on account of presence of particulate matter' Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Sudhir Valia